Arkolith/Insider Trading/IMVT/Form 4

Roivant Sciences Ltd.

Director, 10% OwnerImmunovant, Inc. (IMVT) · full profile →Form 4 · filed Dec 12, 2025
Net Buying
Open-Market Buys
$350.0M
Open-Market Sells
$0
Net Open-Market Flow
$350.0M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 12, 2025Buy(P)16.7M$21.00$350.0M113.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-045409) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML